Correlation Between KENEDIX OFFICE and Takeda Pharmaceutical

Can any of the company-specific risk be diversified away by investing in both KENEDIX OFFICE and Takeda Pharmaceutical at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining KENEDIX OFFICE and Takeda Pharmaceutical into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between KENEDIX OFFICE INV and Takeda Pharmaceutical, you can compare the effects of market volatilities on KENEDIX OFFICE and Takeda Pharmaceutical and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in KENEDIX OFFICE with a short position of Takeda Pharmaceutical. Check out your portfolio center. Please also check ongoing floating volatility patterns of KENEDIX OFFICE and Takeda Pharmaceutical.

Diversification Opportunities for KENEDIX OFFICE and Takeda Pharmaceutical

0.57

Correlation Coefficient

KENEDIX OFFICE  Takeda Pharmaceutical

Very weak diversification

The 3 months correlation between KENEDIX and Takeda is 0.57. Overlapping area represents the amount of risk that can be diversified away by holding KENEDIX OFFICE INV and Takeda Pharmaceutical in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Takeda Pharmaceutical and KENEDIX OFFICE is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on KENEDIX OFFICE INV are associated (or correlated) with Takeda Pharmaceutical. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Takeda Pharmaceutical has no effect on the direction of KENEDIX OFFICE i.e., KENEDIX OFFICE and Takeda Pharmaceutical go up and down completely randomly.

Pair Corralation between KENEDIX OFFICE and Takeda Pharmaceutical

Assuming the 90 days horizon KENEDIX OFFICE is expected to generate 1.28 times less return on investment than Takeda Pharmaceutical. In addition to that, KENEDIX OFFICE is 1.05 times more volatile than Takeda Pharmaceutical. It trades about 0.03 of its total potential returns per unit of risk. Takeda Pharmaceutical is currently generating about 0.05 per unit of volatility. If you would invest  2,425  in Takeda Pharmaceutical on October 8, 2024 and sell it today you would earn a total of  154.00  from holding Takeda Pharmaceutical or generate 6.35% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Weak
Accuracy	100.0%
Values	Daily Returns

KENEDIX OFFICE INV  vs.  Takeda Pharmaceutical

KENEDIX OFFICE INV

Risk-Adjusted Performance

1 of 100

Weak

Compared to the overall equity markets, risk-adjusted returns on investments in KENEDIX OFFICE INV are ranked lower than 1 (%) of all global equities and portfolios over the last 90 days. Despite nearly stable basic indicators, KENEDIX OFFICE is not utilizing all of its potentials. The current stock price disturbance, may contribute to mid-run losses for the stockholders.

Takeda Pharmaceutical

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Takeda Pharmaceutical has generated negative risk-adjusted returns adding no value to investors with long positions. Despite nearly stable basic indicators, Takeda Pharmaceutical is not utilizing all of its potentials. The current stock price disturbance, may contribute to mid-run losses for the stockholders.

Pair Trading with KENEDIX OFFICE and Takeda Pharmaceutical

The main advantage of trading using opposite KENEDIX OFFICE and Takeda Pharmaceutical positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if KENEDIX OFFICE position performs unexpectedly, Takeda Pharmaceutical can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Takeda Pharmaceutical will offset losses from the drop in Takeda Pharmaceutical's long position.

The idea behind KENEDIX OFFICE INV and Takeda Pharmaceutical pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Price Transformation module to use Price Transformation models to analyze the depth of different equity instruments across global markets.